Improvement of asthma control by a concomitant therapy with cineole

H. Worth (Fürth, Germany)

Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments?
Session: Phenotyping asthma: a clue for treatments?
Session type: Oral Presentation
Number: 1876
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Worth (Fürth, Germany). Improvement of asthma control by a concomitant therapy with cineole. Eur Respir J 2011; 38: Suppl. 55, 1876

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evidence-based treatments for severe asthma
Source: Annual Congress 2011 - PG13 ERS/ACCP jointly organised: evidence-based approach to advanced respiratory care
Year: 2011


Efficacy and safety of antibiotic treatment of stable COPD
Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations
Year: 2010


Indacaterol provides effective bronchodilation in patients with COPD regardless of concomitant ICS use
Source: Annual Congress 2010 - Bronchodilators in airways disease
Year: 2010


Knemometry assessment of short-term lower leg growth in children with asthma treated with fluticasone propionate/formoterol combination therapy
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Can flexible combination therapy reduce severe asthma exacerbations associated with common colds?
Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections
Year: 2010

Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid
Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease
Year: 2010



Effects of switching inhaled medication from twice a day to once a day in patients with bronchial asthma
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses
Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010
Year: 2010


Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


NVA237 once daily reduces the percentage of patients with exacerbations of COPD and associated hospitalizations: The GLOW1 trial
Source: Annual Congress 2011 - New treatments for airway disease
Year: 2011


Sputum eosinophilia identifies systemic corticosteroid responsiveness in acute exacerbations of COPD
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011


Effect of aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) on night-time and early morning symptoms in COPD
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014

The use of household cleaning sprays, asthma severity and asthma control in the EGEA study
Source: Annual Congress 2010 - Indoor exposures to irritant chemicals, allergens and moulds and respiratory health of children and adults
Year: 2010

Clinical control of asthma associated with measures of airway inflammation
Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring
Year: 2010


Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening
Source: Eur Respir J 2001; 17: 1083-1088
Year: 2001



Morning and evening administration of inhaled ciclesonide is equally effective in treatment of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 304s
Year: 2002

Once-daily tiotropium Respimat add-on therapy improves lung function and asthma control in moderate symptomatic asthma, independent of baseline characteristics
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017


Increased levels of angiopoientin-1, angiopoientin-2 in sputum supernatant in severe refractory asthma
Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Year: 2010


Fluticasone propionate/formoterol fumarate improves asthma control and reduces exacerbations compared with fluticasone
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013